ATROPINE SULFATE INJECTION USP: Affected lot may contain the presence of glass particulate.
Last updated
Summary
Product
ATROPINE SULFATE INJECTION USP (10ML PREFILLED SYRINGE)
Issue
Health products - Product quality
What to do
Consult your health care professional if you have any health concerns.
Affected products
Brand |
Product Name |
Market Authorization |
Dosage Form |
Strength |
Lot |
|---|---|---|---|---|---|
Atropine Sulfate Injection USP LifeShield Abboject Syringe |
ATROPINE SULFATE INJECTION USP |
DIN 00328154 |
Solution |
Atropine Sulfate 1mg/10mL (0.1mg/mL) |
41152DK |
Issue
Affected lot may contain the presence of glass particulate.
What you should do
- Verify if your product is affected.
- Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health concerns.
- Contact the recalling firm if you have any questions about the recall.
- Report any health product related side effects to Health Canada.
- Report any other health product safety complaints to Health Canada.
Additional information
Background
Depth of recall: Healthcare Establishments
Details
Original published date:
Alert / recall type
Health product recall
Category
Health products - Drugs
Companies
|
Pfizer Canada ULC 17300 Trans-Canada Highway, Kirkland, QC, H9J 2M5 |
Published by
Health Canada
Audience
General public
Healthcare
Industry
Recall class
Type I
Identification number
RA-74317
Get notified
Receive notifications for new and updated recalls and alerts by category.